Transformation of NIH 3T3 cells by enhanced PAR expression

Biochemical and Biophysical Research Communications

Volumn 314, Issue 3, 2004, Pages 891-896

  Platica, Micsunica ^a   Ivan, Elena ^a   Ionescu, Alin ^a   Holland, James F ^a   Mora, Gloria ^c   Tindall, Donald J ^c   Mandeli, John ^b   Unger, Pamela D ^a   Platica, Ovid ^d  

^a MOUNT SINAI SCHOOL OF MEDICINE   (United States)

^b MOUNT SINAI MEDICAL CENTER   (United States)

^c MAYO CLINIC   (United States)

^d SUNY DOWNSTATE MEDICAL CENTER   (United States)

Author keywords

Cell cycle; NIH 3T3 cells; PAR gene; Stable transfection; Tumor growth

Indexed keywords

JTB PROTEIN, HUMAN; MEMBRANE PROTEIN; MESSENGER RNA; OLIGONUCLEOTIDE; PROTEINASE ACTIVATED RECEPTOR; RECOMBINANT PROTEIN; TUMOR PROTEIN;

ANIMAL; ARTICLE; BIOSYNTHESIS; BIOTRANSFORMATION; CELL CYCLE; CELL CYCLE G1 PHASE; CELL CYCLE S PHASE; CELL DIVISION; CELL FUNCTION; CELL STRAIN 3T3; CELL TRANSFORMATION; CHROMOSOME 1; CYTOCHEMISTRY; ECTOPIC TISSUE; FLOW CYTOMETRY; GENE EXPRESSION; GENE EXPRESSION REGULATION; GENE LOCATION; GENETIC TRANSFECTION; GENETICS; MALE; METABOLISM; MOUSE; MOUSE MUTANT; NONHUMAN; ONCOGENE; PHENOTYPE; PRIORITY JOURNAL; PROSTATE TUMOR; PROTEIN EXPRESSION; REGULATORY MECHANISM;

RICKETTSIA SP. PAR;

EID: 1642456649     PISSN: 0006291X     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.bbrc.2003.12.176     Document Type: Article

References (26)

1. Vogelstein B., Fearon E.R., Hamilton S.R., Kern S.E., Preisinger A.C., Leppert M. Genetic alterations during colorectal tumor development. New Engl. J. Med. 319:1988;525-532.
2. Vogelstein B., Kinzler K.W. The multistep nature of cancer. Trends Genet. 9:1993;138-141.
3. Weinstein I.B. Disorders in cell circuitry during multistage carcinogenesis: the role of homeostasis. Carcinogenesis. 21:2000;857-858.
4. Weinberg R. Oncogenes and tumor suppressor genes, CA. Cancer J. Clin. 44:1994;160-170.
5. Munger K. Disruption of oncogene/tumor suppressor networks during human carcinogenesis. Cancer Invest. 20:2002;71-81.
6. Hunter T. Cooperation between oncogenes. Cell. 64:1991;249-270.
7. Magi-Galluzzi C., Loda M. Molecular events in the early phase of prostate carcinogenesis. Eur. Urol. 30:1996;167-176.
8. Deininger M.W., Goldman J.M., Melo J.V. The molecular biology of chronic myeloid leukemia. Blood. 96:2000;3343-3356.
9. Weinberg R.A. Tumor suppressor genes. Science. 254:1991;1138-1146.
10. Hussain S.P., Harris C.C. Molecular epidemiology of human cancer: contribution of mutation spectra studies of tumor suppressor genes. Cancer Res. 58:1998;4023-4037.
11. Krug U., Ganser A., Koeffler H.P. Tumor suppressor genes in normal and malignant hematopoiesis. Oncogene. 21:2002;3475-3495.
12. Smith K.J., Barett T.L., Smith W.F., Skelton H.A. Review of tumor suppressor genes in cutaneous neoplasms with emphasis on cell cycle regulators. Am. J. Dermatol. 3:1998;302-313.
13. Platica O., Chen S., Ivan E., Lopingco M.C., Holland J.F., Platica M. PAR, a novel androgen regulated gene, ubiquitously expressed in normal and malignant cells. Int. J. Oncol. 16:2000;1055-1061.
14. Platica M., Macera M.I., Verma R.S., Platica O. LNCaP-OM, a new androgen resistant prostate cancer subline. In Vitro Cell. Dev. Biol. Anim. 33:1997;147-149.
15. Platica M., Ivan E., Chen S., Holland J.F., Gil J., Mandeli J., Platica O. Stable lower PAR expression decreased DU145 prostate cancer cell growth in SCID mice. Prostate. 49:2001;1-8.
16. Platica M., Chen H.Z., Ciurea D., Gil J., Mandeli J., Hollander V.P. Pituitary extract causes aggregation and differentiation of rat mammary tumor cells MTW9/Pl. Endocrinology. 131:1992;2573-2580.
17. Mattaj I.W. A binding consensus: RNA-protein interactions in splicing, snRNPs, and sex. Cell. 57:1989;1-3.
18. Query C., Bentley R.C., Keene J.D. A common RNA recognition motif identified within a defined U1 RNA binding domain of the 70K U1 snRNP protein. Cell. 57:1989;89-101.
19. Dicker A.J., Serewko M.M., Russell T., Rothnagel J.A., Strutton G.M., Dahler A.L., Saunders N.A. Isolation from a basal cell carcinoma of a functionally distinct fibroblast-like cell type that overexpresses Ptch. J. Invest. Dermatol. 118:2002;859-865.
20. Hatakeyama S., Osawa M., Omine M., Ishikawa F. A novel membrane protein gene at 1q21 rearranged in a jumping translocation. Oncogene. 18:1999;2085-2090.
21. Giet R., Prigent C. Aurora/Ipl1p-related kinases, a new oncogenic family of mitotic serine-threonine kinases. J. Cell Sci. 112:1999;3591-3601.
22. Prigent C., Giet R. Aurora A and mitotic commitment. Cell. 114:2003;531-532.
23. Warner S.L., Bearss D.J., Han H., Von Hoff D.D. Targeting Aurora-2 kinase in cancer. Mol. Cancer Ther. 2:2003;589-595.
24. Takahashi T., Sano B., Nagata T., Kato H., Sugyiama Y., Kunieda K., Kimura M., Okano Y., Saji S. Polo-like kinase 1 (PLK1) is overexpressed in primary colorectal cancers. Cancer Sci. 2:2003;148-152.
25. Bischoff J.R., Anderson L., Zhu Y., Mossie K., Ng L., Souza B., Schryver B., Flanagan P., Clairvoyant F., Ginther C., Chan C.S., Novotny M., Slamon D.J., Plowman G.D. A homologue of Drosophila aurora kinase is oncogenic and amplified in human colorectal cancers. EMBO J. 17:1998;3052-3065.
26. Schultz I.J., Kiemeney L.A., Witjes J.A., Schalken J.A., Willems J.L., Swinkels D.W., de Kok J.B. Survivin mRNA expression is elevated in malignant urothelial cell carcinomas and predicts time to recurrence. Anticancer Res. 23:2003;3327-3331.